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The impact of using BARCIST 
1.0 criteria on quantification of 
BAT volume and activity in three 
independent cohorts of adults
Borja Martinez-Tellez1,2, Kimberly J. Nahon2, Guillermo Sanchez-Delgado1, Gustavo  
Abreu-Vieira2, Jose M. Llamas-Elvira3,4, Floris H. P. van Velden5, Lenka M. Pereira  
Arias-Bouda5,6, Patrick C. N. Rensen  2, Mariëtte R. Boon2 & Jonatan R. Ruiz1
Human brown adipose tissue (BAT) is commonly assessed by cold-induced 18F-fluorodeoxyglucose 
(FDG) PET-CT using several quantification criteria. Uniform criteria for data analysis became available 
recently (BARCIST 1.0). We compared BAT volume and activity following BARCIST 1.0 criteria 
against the most commonly used criteria [Hounsfield Units (HU):-250, -50, standardized uptake 
value (SUV):2.0; HU: Not applied, SUV:2.0 and HU:-180, -10, SUV:1.5] in a prospective study using 
three independent cohorts of men including young lean adults, young overweight/obese adults and 
middle-aged overweight/obese adults. BAT volume was the most variable outcome between criteria. 
While BAT volume calculated using the HU: NA; SUV: 2.0 criteria was up to 207% higher than the BAT 
volume calculated based on BARCIST 1.0 criteria, it was up to 57% lower using the HU: -250, -50; SUV: 
2.0 criteria compared to the BARCIST 1.0. Similarly, BAT activity (expressed as SUVmean) also differed 
between different thresholds mainly because SUVmean depends on BAT volume. SUVpeak was the most 
consistent BAT outcome across the four study criteria. Of note, we replicated these findings in three 
independent cohorts. In conclusion, BAT volume and activity as determined by 18F-FDG-PET/CT highly 
depend on the quantification criteria used. Future human BAT studies should conduct sensitivity 
analysis with different thresholds in order to understand whether results are driven by the selected HU 
and/or SUV thresholds. The design of the present study precludes providing any conclusive threshold, 
but before more definitive thresholds for HU and SUV are available, we support the use of BARCIST 1.0 
criteria to facilitate interpretation of BAT characteristics between research groups.
Brown adipose tissue (BAT) is present and metabolically active in human adults1. In 2009, several studies using 
18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with X-ray computed tomog-
raphy (CT) (18F-FDG-PET/CT) imaging showed that human BAT can be activated upon cold exposure, that 
18F-FDG uptake by BAT is more common in women than in men, and that 18F-FDG uptake by BAT is higher in 
lean than in obese individuals2–5. The capacity of BAT to combust energy as well as its beneficial role in glucose6 
and lipid7 metabolism makes BAT an attractive therapeutic target in combating adiposity and type 2 diabetes.
Currently, 18F-FDG-PET/CT analysis is the most commonly used method to quantify human BAT volume and 
activity1. 18F-FDG-PET provides information about glucose uptake by metabolically active tissues including BAT, 
expressed as standardized uptake value (SUV)8,9. CT, on the other hand, provides anatomical information and 
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allows the identification of various tissues, including adipose tissue and soft tissues, based on the radio-density 
expressed as Hounsfield units (HU). Therefore, quantification of BAT volume and activity depends to a great 
extent on the selection and combination of HU and SUV thresholds1. Due to the lack of consensus on the most 
appropriate HU and SUV thresholds to quantify BAT volume and activity in humans, studies have shown dif-
ferent levels of BAT volume and activity in cohorts with similar characteristics10,11. Consequently, since optimal 
thresholds are not known, current available data on human BAT volume and activity are speculative at best. 
Moreover, the use of different HU and SUV thresholds hampers comparability across studies.
Recently, an expert panel launched a set of recommendations for conducting 18F-FDG-PET/CT analysis of 
human BAT (Brown Adipose Reporting Criteria in Imaging Studies, BARCIST 1.0)1. BARCIST 1.0 recommends 
using a HU range between -190 and -10, and a SUV threshold of [1.2/(lean body mass (LBM)/body mass (BM))]. 
The impact of using the BARCIST 1.0 HU and SUV thresholds compared to the most commonly used protocols 
to quantify BAT volume and activity is currently unknown since, to our knowledge, no studies using these spe-
cific thresholds have been reported yet. It is of interest to better understand the relative differences obtained with 
BARCIST 1.0 thresholds compared to the currently most commonly used thresholds in literature for populations 
with different age and BMI.
Therefore, in the present study we aimed to compare and quantify BAT volume and activity following 
BARCIST 1.0 recommendations against the most commonly used HU and SUV thresholds in three different 
cohorts of men including young lean adults, young overweight/obese adults, and middle-aged overweight/obese 
adults.
Methods
Participants. A total of thirty men from three independent cohorts were included in this prospectively 
designed study. Participants’ characteristics are shown in Table 1. The study cohorts were: (i) 10 young lean adults 
(21–29 years old; BMI 19–24 kg/m2, white Caucasians)12, (ii) 10 young overweight/obese adults (18–25 years 
old; BMI 25–35 kg/m2)13, and (iii) 10 middle-aged overweight/obese adults (35–53 years old; BMI 26–30 kg/m2). 
The study conducted in young overweight/obese adults was approved by the Human Research Ethics Committee 
of both University of Granada (n°924) and Servicio Andaluz de Salud (Centro de Granada, CEI-Granada). The 
Medical Ethical Committee of the Leiden University Medical Center approved the other study cohorts (2473 
and NCT02294084). All volunteers provided written informed consent before participation. All studies were 
performed in accordance with the Declaration of Helsinki.
Systematic review on most commonly used thresholds. To identify the most commonly used HU 
and SUV thresholds for 18F-FDG-PET/CT scans in BAT research, we conducted a systematic literature search on 
MEDLINE (from January 1st 2007 to March 10th 2017) for studies reporting human BAT volume and activity. We 
Young lean adults (N = 10) Young overweight/obese adults (N = 10)
Middle-aged overweight/
obese adults (N = 10)
Age (years) 25 ± 3 22 ± 2 42 ± 6
Height (m) 1.85 ± 0.05 1.78 ± 0.09 1.80 ± 0.05
Weight (kg) 76.0 ± 7.3 92.9 ± 16.1 89.9 ± 7.6
BMI (kg/m2) 22.2 ± 1.6 29.0 ± 3.4 27.8 ± 1.3
Waist-to-hip ratio 0.87 ± 0.04 0.90 ± 0.08 0.96 ± 0.04
Fat mass (kg) 13.4 ± 4.2 31.7 ± 9.7 24.7 ± 6.5
Lean body mass (kg) 59.6 ± 5.9 56.2 ± 7.3 61.9 ± 5.1
Fasting glucose (mmol/l) 4.2 ± 0.3 5.0 ± 0.4 4.7 ± 0.4
Study period March 2013 to June 2013 October 2015 to November 2016 March 2015 to June 2016
Country The Netherlands Spain The Netherlands
Cooling methodology 2 water-perfused blankets (Blanketrol III, Cincinnati USA)
1 water-cooling vest (Polar Products Inc., Ohio, 
USA) with light cool air conditioned room.
2 water-perfused blankets 
(Blanketrol III, Cincinnati 
USA)
Time of cold exposure prior PET/
CT scan
Shivering test + 2 h to 
individualized mild cold
Shivering test (48–72 h before) + 2 h to 
individualized mild cold
Shivering test + 2 h to 
individualized mild cold
PET/CT scanner Gemini TF64 PET/CT, Philips, Netherlands Siemens Biograph 16 PET/CT, Siemens, Germany
Gemini TF64 PET/CT, Philips, 
Netherlands
DEXA scan Lunar iDXA, GE Healthcare, UK QDR 4500 W, HOLOGIC, USA
Lunar iDXA, GE Healthcare, 
UK
18F-FDG (MBq) 152 ± 15 188 ± 11 107 ± 4
Ratio 18F-FDG (MBq) to BMI (kg/m2) 6.8 ± 0.3 6.5 ± 0.8 3.8 ± 0.3
SUV lean body mass 1 threshold (g/ml) 1.54 ± 0.09 1.98 ± 0.17 1.75 ± 0.15
SUVmean (g/ml) of descending aorta 
(reference tissue) 1.18 ± 0.17 1.62 ± 0.23 1.66 ± 0.29
Table 1. Characteristics of participants and study conditions of the three cohorts. Data are 
means ± standard deviation. BMI: Body mass index; DEXA: Dual Energy X-ray Absorptiometry; 18F-
FDG: 18F-fluorodeoxyglucose; MBq: Megabecquerel; PET/CT: Positron Emission Tomography/Computed 
Tomography; SUV: Standardized uptake value.
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used the Medical Subject Heading (MeSH) terms “Adipose Tissue, Brown” in combination with type of popula-
tion (men, women, and adults) and instrument used (“PET/CT”, “PET-CT”, and “18-FDG”). We excluded human 
studies that did not use 18F-FDG-PET/CT scans to assess BAT volume and activity, studies conducted in animal 
models or not written in English, and reviews. In addition, we searched the reference lists of all identified relevant 
publications. No restrictions were considered regarding study design (cross sectional, case-control, cohort study) 
or data collection (prospective or retrospective). To avoid duplicate data, we identified articles that included the 
same group of participants by reviewing inter-study similarities in any of the following characteristics: country in 
which the study was conducted, investigators who performed the study, source of patients, recruitment period, 
and inclusion criteria. When the same investigators reported results obtained on the same group of patients in 
several publications, only the first published study was included.
Cooling protocol. To activate BAT, we applied personalized cooling protocols prior to 18F-FDG-PET/CT 
scans. Slightly different water-cooling methods were used between the different cohorts due to differences in 
local equipment and protocols. In the young lean and middle-aged overweight/obese cohorts two water-perfused 
temperature-controlled mattresses (Blanketrol III, Cincinnati Sub-Zero Products, Cincinnati, OH, USA) were 
used, as previously described12. In short, participants were sandwiched between two water-perfused mattresses 
starting at a temperature of 32 °C, which was subsequently gradually decreased. When shivering occurred (after 
30–40 min), temperature was raised by 3–4 °C and a stable cooling period of 2 h started. In the cohort of young 
overweight/obese adults a water perfused vest (Polar Products Inc., Ohio, USA) was used14. Shivering threshold 
was determined 48–72 h before the 18F-FDG-PET/CT scan. Immediately before the 18F-FDG-PET/CT scan, par-
ticipants wore the water perfused vest for 2 h set at approx. 4 °C above the temperature that caused the onset of 
shivering. In all three studies, after 1 h of stable cooling 18F-FDG was injected (Table 1) and after 2 h of cooling 
18F-FDG-PET/CT imaging was performed.
Body composition. Fat mass and lean body mass were measured by Dual Energy X-ray Absorptiometry 
(DEXA) in the three cohorts (Table 1).
18F-FDG-PET/CT scan. Cold-induced BAT volume and activity were assessed by 18F-FDG-PET/CT scan-
ning. Table 1 shows details of the PET/CT scanners as well as doses of 18F-FDG injected in each study cohort. In 
the three studies, for the CT acquisition a peak kilovoltage of 120 was applied, while for the PET acquisition a scan 
time of 6 min per bed position was set. In total, 6 bed positions were scanned for the young lean and middle-aged 
overweight/obese adults (from top of the head to pelvis) and 2 bed positions for the young overweight/obese 
adults (from atlas vertebra to mid-chest, which was a requirement set by the Human Research Ethics Committee 
to limit radiation burden).
Quantification of human BAT volume and activity. PET/CT images were analyzed using the Beth 
Israel plugin for FIJI2 software by two trained researchers (BMT and KJN)15. Disagreements between both 
researchers were arranged in a consensus meeting. The regions of interest (ROIs) were semi-automatically 
outlined from atlas vertebrae (Cervical 1) to thoracic vertebrae 4 (see Figure S1) using a 3D-Axial technique11. 
The ROIs were placed in this range because (i) this region predominantly shows BAT activity and (ii) it is the 
region that is consistently scanned in all three study cohorts. Regions such as mouth, nose, or thyroid were not 
included to avoid potential false positives within the ROIs. We calculated the standardized uptake value (SUV) as 
[18F]-FDG uptake (kBq/mL)/(injected dose [kBq]/patient weight [g])]. We defined BAT volume, SUVmean, BAT 
metabolic activity, SUVmax and SUVpeak following BARCIST 1.0 criteria1. In short, BAT volume was calculated 
as the sum of the volumes identified as BAT in each ROI (1 to 6, see Figure S1). SUVmean was calculated by the 
weighted average of SUVmean derived from each ROI (1 to 6). SUVpeak was the highest average SUV in a 1 ml spher-
ical volume. This sphere may, or may not, be centered on the highest SUVmax over all ROIs (1 to 6). We also drew 
a ROI on the descending aorta as reference tissue (Table 1)1. To quantify BAT, we applied the criteria of BARCIST 
1.0, in addition to the three most used combinations of thresholds detected in the systematic review (see below).
Statistical analysis. Differences across HU and SUV thresholds were analyzed using analysis of variance 
(ANOVA) with Bonferroni adjustments for post-hoc comparisons. Separate analyses were conducted for each 
study cohort. The inter-observer (BMT and KJN) reliability was assessed using Lin’s concordance coefficient 
(LCC)16. All analyses were conducted using the Statistical Package for Social Sciences (SPSS, v. 22.0, IBM SPSS 
Statistics, IBM Corporation) and the level of significance was set to ≤0.05. Data are presented as mean ± standard 
deviation unless otherwise stated.
Results
Characteristics of participants. Table 1 summarizes the characteristics of the participants and the study 
conditions in the three cohorts.
Systematic review: Selection of HU and SUV thresholds. After having read titles and abstracts, 344 
studies were excluded from a total of 471; 131 were checked for relevance (full text); and 123 met the inclusion 
criteria. After excluding redundant studies, i.e. studies that used the same participants and images, a total of 
116 studies were finally included (Table S1). Table 2 shows a summary of the HU and SUV thresholds used in 
the quantification of human BAT by 18F-FDG-PET/CT. We found nine different combinations of HU and SUV 
thresholds published twice or more, and 26 different combinations of HU and SUV thresholds published just 
once. HU and/or SUV thresholds were not mentioned in as many as 32 studies. We selected the three most 
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frequently used combinations of HU and SUV thresholds (Table 2): HU: -250, -50; SUV: 2.0, HU: N.A.; SUV: 2.0 
and HU: -180, -10; SUV: 1.5 for comparison with the BARCIST 1.0 criteria.
High inter-observer reliability was found regardless of thresholds applied. Lin’s concordance 
coefficient (LCC) of BAT volume and in the three cohorts was above 0.950, except in one case (0.906; SUVpeak in 
overweight/obese adults; HU: NA, SUV: 2.0; Table S2). When BARCIST 1.0 criteria were applied, the LCC were 
0.962–0.996, 0.980–0.996 and 0.983–1.000, for BAT volume, SUVmean, and SUVpeak, respectively (Table S2).
The combination of HU and SUV thresholds markedly affects estimation of BAT volume and 
activity across different cohorts. Representative images of BAT volume and activity of the three study 
cohorts resulting from different HU and SUV threshold combinations are shown in Fig. 1. Firstly, we deter-
mined the quantitative effect of the four threshold combinations on BAT volume in young lean adults (Fig. 2A), 
young overweight/obese adults (Fig. 2B), and middle-aged overweight/obese adults (Fig. 2C). Compared to the 
BARCIST 1.0 criteria, higher BAT volumes were consistently observed using the HU: NA; SUV: 2.0 criteria in 
young lean adults [+155%; 249 (186, 312) ml; mean (95% CI)], young overweight/obese adults [+207%; 244 
(114, 374) ml], and middle-aged overweight/obese adults [+124%; 106 (42, 170) ml]. In contrast, BAT volumes 
estimated with the HU: -250, -50; SUV: 2.0 criteria compared to the BARCIST 1.0 criteria, yielded significantly 
smaller values in young lean adults [-57%; 92 (79, 106) ml], young overweight/obese adults [-42%; 49 (29, 70) ml], 
and middle-aged overweight/obese adults [-54%; 46 (28, 64) ml] (see Table S3). No significant differences were 
observed between BAT volumes estimated by HU: -180, -10; SUV: 1.5 criteria compared to BARCIST 1.0 criteria 
in young lean adults [0%; 0 (-5, 5) ml], however, we found higher BAT volumes in young overweight/obese adults 
[+40%; 47 (24, 69) ml] and middle-aged overweight/obese adults [+45%; 38 (18, 58)].
HU SUV ≥ No. of studies: 116
-250; -50 2.0 20
Not used/Not reported 2.0 10
-180; -10 1.5 7
-300; -10 2.0 4
-100; -10 1.0 3
-250; -10 2.0 3
-150; -30 1.5 2
-250; -50 SUV different at 2.0 7
-180; -10 SUV different at 1.5 2
Other combinations 26
Not reported Not reported 32
Table 2. Summary of Hounsfield units (HU) and standardized uptake value (SUV) thresholds used for 
quantification of human brown adipose tissue by 18F-FDG-PET/CT scans from January 1, 2007 to March 10, 
2017. See Table S1 for references and details of Hounsfield units, standardized uptake value, and software used 
to quantify human brown adipose tissue.
Figure 1. Representative images of brown adipose tissue volume and activity of the three study cohorts by 
threshold of Hounsfield units (HU) and standardized uptake value (SUV). Blue dots indicate BAT volume and 
red dots indicate maximal BAT activity (SUV max). BMI: Body mass index; HU: Hounsfield units; NA: Not 
applied; SUV: Standardized uptake value.
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HU and SUV thresholds moderately affect estimation of BAT activity (SUVmean) across differ-
ent cohorts. We next determined the effect of the four threshold combinations on SUVmean in young lean 
adults (Fig. 2D), young overweight/obese adults (Fig. 2E), and middle-aged overweight/obese adults (Fig. 2F). 
Compared to the BARCIST 1.0 criteria, higher SUVmean were observed using the HU: -250, -50; SUV: 2.0 cri-
teria in young lean adults [+18%; 0.8 (0.9–0.6) g/ml] and in middle-aged overweight/obese adults [+13%; 0.3 
(0.2–0.5) g/ml]. In young lean adults, a lower SUVmean was estimated using the HU: NA; SUV: 2.0 criteria com-
pared to BARCIST 1.0 criteria [-9%; 0.4 (0.2, 0.6) g/ml]. Lower BAT activity was detected using HU: -180, -10; 
SUV: 1.5 criteria against BARCIST 1.0 criteria in young overweight/obese adults [-14%; 0.5 (0.4, 0.7) g/ml] and 
middle-aged overweight/obese adults [-11%; 0.3 (0.2–0.4) g/ml] (Table S3).
HU and SUV thresholds slightly affect estimation of maximal BAT activity (SUVpeak) values 
across different cohorts. In addition, we determined the effect of the four threshold combinations on 
SUVpeak in young lean adults (Fig. 2G), young overweight/obese adults (Fig. 2H), and middle-aged overweight/
obese adults (Fig. 2I). We found similar results in the SUVpeak values (all P > 0.05), however, there were significant 
differences in the middle-aged overweight/obese adults, where SUVpeak values calculated with HU: NA; SUV: 
2.0 criteria were higher than calculated with BARCIST 1.0 criteria [+10%; 0.6 (0.2, 0.9) g/ml]. Figure S2 shows 
means and 95% CI of BAT volume and activity determined by various thresholds of HU and SUV for the three 
study cohorts.
Discussion
To our knowledge, the present study is the first empirical investigation to compare and quantify BAT volume 
and activity following BARCIST 1.0 criteria against the most used HU and SUV thresholds in three independent 
cohorts of men of different age and BMI. We observed that BAT volume calculated using the HU: NA; SUV: 2.0 
Figure 2. Brown adipose tissue (BAT) volume and activity determined by various thresholds of Hounsfield 
unit (HU) and Standardized uptake value (SUV) for three study cohorts. BAT volume (A–C), SUVmean (D–F), 
and SUVpeak (G–I) were determined in young lean adults (A,D,G), young overweight/obese adults (B,E,H), 
and middle-aged overweight/obese adults (C,F,I). Data are means and standard deviation (n = 10 per cohort). 
Significant differences between thresholds are indicated by parallel horizontal bars (all P ≤ 0.05). BARCIST 1.0: 
HU:-190, -10; SUV: Individualized [1.2/(lean body mass/body mass)]; BMI: Body mass index; NA: Not applied. 
See Table S4 for exact absolute and relative differences between thresholds.
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criteria may differ up to 2.6-fold, 3.1-fold, and 2.2-fold from the BAT volume calculated based on BARCIST 1.0 
criteria in young normal-weight, young overweight/obese, and middle-aged overweight/obese adults, respec-
tively. Similarly, BAT activity (expressed as SUVmean), based on BARCIST 1.0 criteria differed up to 18% and 
13% when compared with BAT activity based on the HU: -250, -50; SUV: 2.0 criteria, for young lean adults and 
middle-aged overweight/obese adults, respectively. On the other hand, differences were not significant when 
maximal BAT activity was expressed as SUVpeak for young cohorts, while we found that SUVpeak based on the 
HU: NA; SUV: 2.0 was 10% higher than calculated with BARCIST 1.0 criteria in middle-aged overweight/obese 
adults. The findings of this study show that human BAT volume and to a lesser extent BAT activity (expressed 
as SUVmean) depend largely on the selected HU and SUV thresholds. Moreover, we observed that the various 
threshold combinations similarly influenced BAT volume and BAT activity (SUVmean) in the three cohorts inde-
pendently of age, BMI or different methodologies applied to activate and measure BAT17.
HU and SUV thresholds markedly affect BAT volume across different cohorts. The scientific com-
munity has been speculating about the volume of BAT that is present in adult men, and showed mean values of 
approx. 70 ml3, 100 ml2,18, 300 ml19, and 450 ml20. This highlights the knowledge gap regarding the amount of BAT 
present in adults and that maximizing its volume and metabolic activity could impact human physiology. We found 
that the highest BAT volumes were consistently observed with those thresholds that did not apply a criterion for HU 
(i.e. HU: NA, SUV: 2.0). Because the gold standard to quantify BAT is the 18F-FDG-PET in combination with CT, it 
is evident that a threshold of HU should be applied, although the most appropriate threshold of HU remains to be 
elucidated. We observed lower BAT volumes with the most frequently used threshold combination in literature (HU: 
-250, -50, SUV: 2.0) compared to BARCIST 1.0. These differences could be based on the fact that BARCIST 1.0 uses 
an HU range starting at -10 while the most commonly protocol used an HU range starting at -50, albeit it is known 
that the range of adipose tissue in the CT images starts at an HU value of -1011,21. Moreover, it was recently shown22 
that the density of the BAT might change after a cold exposure, especially in the range from -50 to -10. Actually, it 
is not feasible to distinguish BAT from WAT or other tissues using exclusively CT criteria. Thus, more studies are 
needed to increase our understanding of BAT density measured by a CT scan23.
The main advantage of the BARCIST 1.0 recommendations is the inclusion of an individualized SUV thresh-
old adapted to the individual’s lean body mass. Estimated BAT volumes did not differ between BARCIST 1.0 and 
HU: -180, -10; SUV: 1.5 criteria in the young lean adults, probably because the SUV criteria were virtually iden-
tical using both thresholds (1.54 ± 0.09 vs. 1.5 g/ml, respectively). Nevertheless, we found higher estimated BAT 
volume with HU: -180, -10; SUV: 1.5 compared to BARCIST 1.0, because the SUV threshold applied in BARCIST 
was higher for young overweight/obese adults and middle-aged overweight/obese adults (1.98 ± 0.17 g/ml and 
1.75 ± 0.15 g/ml, Table 1). Therefore, the relative changes in BAT volume are largely influenced by the use of a 
SUV threshold corrected by lean body mass1,11.
HU and SUV thresholds moderately affect BAT activity (SUVmean) across different cohorts. SUVmean 
is the average SUV within a volume, therefore, if BAT volume differs due to HU or SUV thresholds in the three cohorts, 
SUVmean is also expected to differ by the thresholds selection. Indeed, SUVmean is not consistent across studies as it 
is influenced by many methodological factors as described previously17 such as cooling protocols or instruments, as 
well as study populations8,9. We showed that when a SUV individualized threshold was used and the SUV values are 
alike (such as HU: -180, -10; SUV: 1.5 criteria in young lean adults), then the SUVmean values are similar. However, we 
observed that an application of a higher SUV threshold results in higher SUVmean values, regardless of the HU thresh-
olds applied or the cohort studied because the SUV threshold of 2.0 includes higher 18F-FDG uptake of BAT deposits. 
On the other hand, when an HU threshold was omitted (i.e. HU: NA; SUV: 2.0 criteria), the SUVmean values were 
lower regardless of the cohort studied. In this case, all 18F-FDG present in the selected ROIs of the PET images is used 
for quantification of BAT activity even though part of 18F-FDG would represent uptake by other tissues that were not 
excluded for the analysis due to lack of HU criteria.
HU and SUV thresholds slightly affect maximal BAT activity (SUVpeak) values across different 
cohorts. BARCIST 1.0 recommends to report SUVpeak instead of SUVmax to avoid overestimation in the quan-
tification of BAT activity1, because SUVmax is the single highest uptake pixel in the ROI and could easily be an 
outlier whereas SUVpeak is the highest average SUV in a 1 cc spherical volume, thereby reducing a potential effect 
of outliers. This sphere may, or may not, be centered on the highest SUVmax. Letiner et al.11 found that PET image 
resolution substantially influences observed BAT SUVmax but whether this resolution also affects SUVpeak in cur-
rently unknown. Compared to the BARCIST 1.0 criteria, we found similar SUVpeak values across thresholds in 
young lean men and overweight/obese men. However, differences were observed between the thresholds that did 
not use HU vs. all the other thresholds in middle-aged overweight-obese adults. This could be based on the lower 
amount of 18F-FDG injected with respect to the size/body weight of the participant [ratio between amount of 
18F-FDG to BMI (6.8 ± 0.3, 6.5 ± 0.8, and 3.8 ± 0.3 MBq/(kg/m2) in young lean adults, young overweight/obese 
adults, and middle-aged overweight/obese adults, respectively]. Therefore, the distribution of the tracer among 
the various tissues may partially explain this finding. In fact, lower doses of 18F-FDG, as used in the cohort of 
middle-aged overweight/obese adults, may increase noise in the image and, therefore, raise SUVpeak levels1,8,9. We 
found that SUVmax was located in BAT regions irrespective of the threshold used in young lean and young over-
weight/obese men. However, in middle-aged overweight/obese men, SUVmax was found in an unexpected region 
when no threshold for HU was used. Therefore, omission of HU threshold may have resulted in an artificial 
SUVmax and consequently SUVpeak, especially in the middle-aged overweight-obese men who received a low dose 
of 18F-FDG. Similar differences between thresholds and cohort studies were found with SUVmax (data not shown). 
Therefore, in light of these findings, we support that SUVpeak is the most consistent BAT-related outcome between 
criteria in the three independently cohorts of adults.
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Limitations. We quantified BAT in six different ROIs from cerebellum to thoracic vertebra 4 (Figure S1). 
Although most of the BAT detected in humans is localized in the areas covered by the selected ROIs11, we may 
have missed BAT depots in axillary, paraspinal or abdominal adipose tissue located in anatomical areas beneath 
the thoracic vertebra 411. Our ROIs did not include mouth, nose, or thyroid to avoid false positive results, yet, 
results persisted when a single ROI from cerebellum to thoracic vertebrae 4 was drawn and when HU criteria 
were applied (data not shown). In addition, we do not know if these findings can be replicated when the SUV 
threshold of BARCIST criteria is used in combination with other ranges of HU. Besides the selection of HU and 
SUV thresholds, quantification of human BAT volume and activity also depends on other methodological issues 
such as the cooling protocol, 18F-FDG-PET/CT methodology, segmentation software17, tracer used (18F-FDG vs. 
18F-FTHA24), intrinsic factors of the participants such as age, sex, or body composition, or extrinsic factors as 
outdoor temperature25 or daily light26, which limit comparisons across studies. To improve the understanding 
of human BAT measured by 18F-FDG-PET/CT, the reconstruction settings should be harmonized in a similar 
manner as proposed by the EANM guidelines for 18F-FDG tumor PET imaging27. In the present study, the PET/
CT scans from young overweight/obese adults did not follow these guidelines, therefore we cannot guarantee 
that the recovery coefficients of the used reconstructions are the same. Moreover, methodological differences 
between cohorts did not allow us to check whether differences between HU and SUV thresholds are of different 
magnitude. Also the use of different cooling techniques (cooling vests vs. mattresses) and protocols might have 
introduced some bias. This study included only healthy male adults. The results should be applicable to other 
populations, such as women and men with different fat distributions, although this should be verified by replica-
tion in other cohorts with larger sample size. Moreover, biopsies of BAT-classical depots would be necessary to 
identify the density window (in terms of HU) of this tissue in different populations.
Conclusions
BAT volume and activity as determined by 18F-FDG PET/CT highly depend on the quantification criteria used. 
Future human BAT studies should conduct sensitivity analysis with different thresholds in order to understand 
whether results are driven by the selected HU and SUV thresholds. According to our findings, when following 
an individualized cooling protocol, SUVpeak is the most consistent marker of maximal BAT activity across study 
cohorts independent of the HU and SUV threshold used, which may therefore facilitate comparisons across 
studies. The design of the present study precludes providing any conclusive threshold, but before more definitive 
thresholds for HU and SUV are available, we support the use of BARCIST 1.0 criteria to facilitate interpretation 
of BAT characteristics between research groups.
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